SE9902388D0 - Method for purification of proteins - Google Patents

Method for purification of proteins

Info

Publication number
SE9902388D0
SE9902388D0 SE9902388A SE9902388A SE9902388D0 SE 9902388 D0 SE9902388 D0 SE 9902388D0 SE 9902388 A SE9902388 A SE 9902388A SE 9902388 A SE9902388 A SE 9902388A SE 9902388 D0 SE9902388 D0 SE 9902388D0
Authority
SE
Sweden
Prior art keywords
iii
antithrombin
impurities
solution
methods
Prior art date
Application number
SE9902388A
Other languages
English (en)
Inventor
Stefan Winge
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9902388A priority Critical patent/SE9902388D0/sv
Publication of SE9902388D0 publication Critical patent/SE9902388D0/sv
Priority to DK00944505.7T priority patent/DK1185551T3/da
Priority to DE60044812T priority patent/DE60044812D1/de
Priority to CA2376986A priority patent/CA2376986C/en
Priority to JP2001505550A priority patent/JP4521143B2/ja
Priority to EP00944505A priority patent/EP1185551B1/en
Priority to PCT/SE2000/001193 priority patent/WO2000078792A1/en
Priority to AU58594/00A priority patent/AU776861B2/en
Priority to ES00944505T priority patent/ES2349678T3/es
Priority to PT00944505T priority patent/PT1185551E/pt
Priority to AT00944505T priority patent/ATE477267T1/de
Priority to NZ516235A priority patent/NZ516235A/xx
Priority to US09/598,883 priority patent/US6518406B1/en
Priority to NO20016174A priority patent/NO324627B1/no
Priority to US10/200,338 priority patent/US20030083471A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9902388A 1999-06-23 1999-06-23 Method for purification of proteins SE9902388D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE9902388A SE9902388D0 (sv) 1999-06-23 1999-06-23 Method for purification of proteins
NZ516235A NZ516235A (en) 1999-06-23 2000-06-08 Method for purification of proteins
PCT/SE2000/001193 WO2000078792A1 (en) 1999-06-23 2000-06-08 Method for purification of proteins
ES00944505T ES2349678T3 (es) 1999-06-23 2000-06-08 Procedimiento de purificación de proteínas.
CA2376986A CA2376986C (en) 1999-06-23 2000-06-08 Method for purification of proteins
JP2001505550A JP4521143B2 (ja) 1999-06-23 2000-06-08 タンパク質の精製法
EP00944505A EP1185551B1 (en) 1999-06-23 2000-06-08 Method for purification of proteins
DK00944505.7T DK1185551T3 (da) 1999-06-23 2000-06-08 Fremgangsmåde til oprensning af proteiner
AU58594/00A AU776861B2 (en) 1999-06-23 2000-06-08 Method for purification of proteins
DE60044812T DE60044812D1 (de) 1999-06-23 2000-06-08 Methode zur reinigung von proteinen
PT00944505T PT1185551E (pt) 1999-06-23 2000-06-08 Método para purificação de proteínas
AT00944505T ATE477267T1 (de) 1999-06-23 2000-06-08 Methode zur reinigung von proteinen
US09/598,883 US6518406B1 (en) 1999-06-23 2000-06-21 Method for purification of proteins
NO20016174A NO324627B1 (no) 1999-06-23 2001-12-18 Fremgangsmate ved opprenskning av antitrombin-III
US10/200,338 US20030083471A1 (en) 1999-06-23 2002-07-23 Method for purification of proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902388A SE9902388D0 (sv) 1999-06-23 1999-06-23 Method for purification of proteins

Publications (1)

Publication Number Publication Date
SE9902388D0 true SE9902388D0 (sv) 1999-06-23

Family

ID=20416211

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902388A SE9902388D0 (sv) 1999-06-23 1999-06-23 Method for purification of proteins

Country Status (13)

Country Link
EP (1) EP1185551B1 (sv)
JP (1) JP4521143B2 (sv)
AT (1) ATE477267T1 (sv)
AU (1) AU776861B2 (sv)
CA (1) CA2376986C (sv)
DE (1) DE60044812D1 (sv)
DK (1) DK1185551T3 (sv)
ES (1) ES2349678T3 (sv)
NO (1) NO324627B1 (sv)
NZ (1) NZ516235A (sv)
PT (1) PT1185551E (sv)
SE (1) SE9902388D0 (sv)
WO (1) WO2000078792A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4651536B2 (ja) * 2003-04-17 2011-03-16 田辺三菱製薬株式会社 組換えアンチトロンビンの製造方法
EP1685852A1 (en) * 2005-02-01 2006-08-02 Fondation pour la Recherche Diagnostique Set of disposable bags for viral inactivation of biological fluids
US20060223988A1 (en) * 2005-04-05 2006-10-05 National Research Laboratories, Ltd. High Resolution Methods and Precipitating Reagents for Isolating Proteins from Proteinaceous Material
CN103059129B (zh) * 2013-01-28 2015-02-11 贵州泰邦生物制品有限公司 制造人抗凝血酶-iii制品的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
US4977246A (en) * 1989-06-06 1990-12-11 Rorer Pharmaceutical Corporation High recovery process for antihemophilic factor
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
JPH08109140A (ja) * 1994-10-12 1996-04-30 Green Cross Corp:The 高血圧症予防治療剤

Also Published As

Publication number Publication date
AU776861B2 (en) 2004-09-23
NO20016174L (no) 2002-02-21
DK1185551T3 (da) 2010-11-22
EP1185551B1 (en) 2010-08-11
NZ516235A (en) 2004-01-30
CA2376986C (en) 2010-03-16
AU5859400A (en) 2001-01-09
WO2000078792A1 (en) 2000-12-28
PT1185551E (pt) 2010-11-12
NO20016174D0 (no) 2001-12-18
ES2349678T3 (es) 2011-01-10
JP2003502438A (ja) 2003-01-21
ATE477267T1 (de) 2010-08-15
NO324627B1 (no) 2007-11-26
CA2376986A1 (en) 2000-12-28
EP1185551A1 (en) 2002-03-13
JP4521143B2 (ja) 2010-08-11
DE60044812D1 (de) 2010-09-23

Similar Documents

Publication Publication Date Title
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
TNSN95061A1 (fr) Derives d'oxalylamino-benzofuranne et benzothienyle
TR200103476T2 (tr) A-beta peptid bileşimleri ve bunları hazırlama yöntemleri
BR0008759A (pt) Métodos para a produção de proteinas contendo resìduos de cisteina livre
NO20050917L (no) Thiomolybdatanaloger og anvendelser derav
SI1151007T1 (sl) Postopek za pripravo pripravka na osnovi fibrinogena in fibronektina in proteinski sestavki, ki jihlahko dobimo po tem postopku
DE69512416D1 (de) Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
NO20075708L (no) Pegylert G-CSF-polypeptider og fremgangsmater for fremstilling av samme
ATE537249T1 (de) Wiedergewinnung von gewebefunktion nach verabreichung von b-zellen an verletztes gewebe
EP2301569A3 (en) Vaccine and method for treatment of neurodegenerative diseases
PT1487468E (pt) Compartimento desmontavel a prova deassalto.
ATE81510T1 (de) Loeslichkeits-, reinigungs- und charakterisierungsverfahren fuer proteine aus unloeslichen proteinaggregaten oder proteinkomplexen und diesbezuegliche praeparate.
SE9902388D0 (sv) Method for purification of proteins
DK1181024T3 (da) Anvendelse af glycosaminoglycaner til behandling af senil demens
TW224143B (sv)
DE60041067D1 (de) Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente
ES2132872T3 (es) Procedimiento de purificacion de diacetilreina.
FR2669221B1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
FR2672895B1 (fr) Procede de purification d'une proteine fortement glycosylee.
NO20033860L (no) Fremgangsmåte for fjernelse av kalsium fra en sulfatopplösning i sinkprosess
IL115293A (en) Method for the purification of an anti-inflammatory factor anti-inflammatory factor obtained by this method and pharmaceutical compositions containing the same
DE60104685D1 (de) Verfahren zur herstellung eines reinen, pharmacopoiealgrad amorphes form von cefuroxim axetil
ATE297385T1 (de) Verfahren zur reinigung von 2-chlor-5- chlormethylthiazol
ATE323760T1 (de) Verfahren zur herstellung eines eine hyaluronidase enthaltenden präparats
DE60236114D1 (de) Zwitterkristall aus menschlicher Papillomavirus-E2-Transaktivierungsdomäne und einem Inhibitor sowie Roentgenstrukturkoordinaten, die die inhibitorbindende Tasche definieren